To view this email as a web page, click here.
 
FDA clears first ready-to-use insulin for IV infusion
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
Read more
 
Experts debate drug pricing policies
Experts debate the effects of President Trump's proposed "favored nations" policy and high hospital drug prices on the overall US healthcare system.
Read more
 
Overactive bladder drug not linked to CV events
A popular drug for overactive bladder was not associated with an increased risk for cardiovascular (CV) events compared with other treatments, according to a new study.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.